Smart Delivery of Copper Complexes for Triple-Negative Breast Cancer From Bioinorganic Design to Antitumor Activity

- 344208
Lecture
Favorite this paper
How to cite this paper?
Abstract

In this study, the copper-complex (CuL1), which has demonstrated anticancer activity, was encapsulated into Eudragit®-based nanoparticles to enhance its effects against TNBC cell lines. Two nanosystems were prepared by nanoprecipitation followed by ultrasonication, using  Eudragit®  E100/S100  (ES-CuL1)  or  Eudragit®  E100/NE100D  (ENE-CuL1).  Both formulations showed encapsulation efficiencies of CuL1 above 90 % and in vitro
controlled drug release over 72 h. Cytotoxicity and apoptosis were evaluated in 2D monolayers and 3D spheroids
of TNBC. Notably, ES-CuL1 enhances the cytotoxic activity of CuL1, showing increased cytotoxicity across all 2D
cell lines. Consistently, the encapsulated complex significantly reduced clonogenic survival from 0.5 μM onward
and induced a higher proportion of late apoptotic cells in all tested lines. In 3D models, ES-CuL1 produced similar  effects to the free drug in 4T1 spheroids but elicited a stronger cytotoxic response in Hs 578T spheroids, sug-gesting  improved  penetration  and  retention  in  tumor-like  structures. 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 National University of La Plata
Track
  • Lecture
Keywords
Copper complexes
TNBC
Mechanism of action
Drug delivery
Nanoparticles